Cargando…

Correction to “Design of Reversible, Cysteine-Targeted Michael Acceptors Guided by Kinetic and Computational Analysis”

Detalles Bibliográficos
Autores principales:	Krishnan, Shyam, Miller, Rand M., Tian, Boxue, Mullins, R. Dyche, Jacobson, Matthew P., Taunton, Jack
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Chemical Society 2014
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4277773/ http://dx.doi.org/10.1021/ja510773c

Ejemplares similares

Design of Reversible, Cysteine-Targeted Michael Acceptors Guided by Kinetic and Computational Analysis
por: Krishnan, Shyam, et al.
Publicado: (2014)

Computational Study of the Addition of Methanethiol to 40+ Michael Acceptors as a Model for the Bioconjugation of Cysteines
por: Costa, Anna M., et al.
Publicado: (2021)

Reversible targeting of noncatalytic cysteines with chemically tuned electrophiles
por: Serafimova, Iana M., et al.
Publicado: (2012)

Impact of the Warhead of Dipeptidyl Keto Michael Acceptors on the Inhibition Mechanism of Cysteine Protease Cathepsin L
por: Fernández-de-la-Pradilla, Adrián, et al.
Publicado: (2023)

Cu-catalyzed carboboration of acetylene with Michael acceptors
por: Cheng, Tairan, et al.
Publicado: (2022)

Nucleophilicity of Glutathione: A Link to Michael Acceptor Reactivities
por: Mayer, Robert J., et al.
Publicado: (2019)

Trifluoromethylcinnamanilide Michael Acceptors for Treatment of Resistant Bacterial Infections
por: Strharsky, Tomas, et al.
Publicado: (2022)

Michael acceptor molecules in natural products and their mechanism of action
por: Liang, Song-Ting, et al.
Publicado: (2022)

Impact of the structures of macrocyclic Michael acceptors on covalent proteasome inhibition
por: Kitahata, S., et al.
Publicado: (2017)

A programmable chemical switch based on triggerable Michael acceptors
por: Zhuang, Jiaming, et al.
Publicado: (2020)

Chemopreventive Agents from Physalis minima Function as Michael Reaction Acceptors
por: Men, Ruizhi, et al.
Publicado: (2016)

Asymmetric Primaquine and Halogenaniline Fumardiamides as Novel Biologically Active Michael Acceptors
por: Rajić, Zrinka, et al.
Publicado: (2018)

A Simple Zinc-Mediated Method for Selenium Addition to Michael Acceptors
por: Nacca, Francesca Giulia, et al.
Publicado: (2020)

Asymmetric tandem conjugate addition and reaction with carbocations on acylimidazole Michael acceptors
por: Mudráková, Brigita, et al.
Publicado: (2023)

Kinetic prediction of reverse intersystem crossing in organic donor–acceptor molecules
por: Aizawa, Naoya, et al.
Publicado: (2020)

Copper-catalyzed asymmetric conjugate addition of organometallic reagents to extended Michael acceptors
por: Schmid, Thibault E, et al.
Publicado: (2015)

Copper-catalyzed enantioselective conjugate addition of organometallic reagents to challenging Michael acceptors
por: Pichon, Delphine, et al.
Publicado: (2020)

Development of Urea-Bond-Containing Michael Acceptors as Antitrypanosomal Agents Targeting Rhodesain
por: Previti, Santo, et al.
Publicado: (2022)

Improvement of the Chemical Reactivity of Michael Acceptor of Ethacrynic Acid Correlates with Antiproliferative Activities
por: El Abbouchi, Abdelmoula, et al.
Publicado: (2023)

Chemical reaction networks based on conjugate additions on β′-substituted Michael acceptors
por: Spitzbarth, Benjamin, et al.
Publicado: (2023)

Synthesis of Benzocycloalkanone-Based Michael Acceptors and Biological Activities as Antimalarial and Antitrypanosomal Agents
por: Mijoba, Ali, et al.
Publicado: (2023)

Inhibition of XPO-1 Mediated Nuclear Export through the Michael-Acceptor Character of Chalcones
por: Gargantilla, Marta, et al.
Publicado: (2021)

Development of Reduced Peptide Bond Pseudopeptide Michael Acceptors for the Treatment of Human African Trypanosomiasis
por: Previti, Santo, et al.
Publicado: (2022)

A Genetically Encoded aza-Michael Acceptor for Covalent Cross-Linking of Protein–Receptor Complexes
por: Furman, Jennifer L., et al.
Publicado: (2014)

Conjugated nitrosoalkenes as Michael acceptors in carbon–carbon bond forming reactions: a review and perspective
por: Boyko, Yaroslav Dmitrievich, et al.
Publicado: (2017)

HFIP Mediates a Direct C−C Coupling between Michael Acceptors and Eschenmoser's salt
por: Lemmerer, Miran, et al.
Publicado: (2022)

International Society for Computational Biology Honors Michael Ashburner and Olga Troyanskaya with Top Bioinformatics/Computational Biology Awards for 2011
por: Mullins, Justin, et al.
Publicado: (2011)

Exploring of drug leads from diversity-oriented Michael-acceptor library derived from natural products
por: Deng, Xu, et al.
Publicado: (2012)

Lewis acid-promoted cascade reaction for the synthesis of Michael acceptors and its application in a dimerization reaction
por: Zhao, Xiao-Jing, et al.
Publicado: (2017)

Naphthoquinones as Covalent Reversible Inhibitors of Cysteine Proteases—Studies on Inhibition Mechanism and Kinetics
por: Klein, Philipp, et al.
Publicado: (2020)

The Emerging Therapeutic Potential of Nitro Fatty Acids and Other Michael Acceptor-Containing Drugs for the Treatment of Inflammation and Cancer
por: Piesche, Matthias, et al.
Publicado: (2020)

Tuneable access to indole, indolone, and cinnoline derivatives from a common 1,4-diketone Michael acceptor
por: El-Marrouki, Dalel, et al.
Publicado: (2020)

Identification of Potential Drug Targets of Broad-Spectrum Inhibitors with a Michael Acceptor Moiety Using Shotgun Proteomics
por: Chu, Hao-Wei, et al.
Publicado: (2021)

Rigidified Bis(sulfonyl)ethylenes as Effective Michael Acceptors for Asymmetric Catalysis: Application to the Enantioselective Synthesis of Quaternary Hydantoins
por: Villaescusa, Leire, et al.
Publicado: (2023)

Oxidoreductase activity is necessary for N-glycosylation of cysteine-proximal acceptor sites in glycoproteins
por: Cherepanova, Natalia A., et al.
Publicado: (2014)

Cytoskeleton dynamics
por: Mullins, Dyche
Publicado: (2011)

New hits as phase II enzymes inducers from a focused library with heteroatom–heteroatom and Michael-acceptor motives
por: Cabrera, Mauricio, et al.
Publicado: (2015)

Polyphotosensitizer‐Based Nanoparticles with Michael Addition Acceptors Inhibiting GST Activity and Cisplatin Deactivation for Enhanced Chemotherapy and Photodynamic Immunotherapy
por: Zhao, Qinxin, et al.
Publicado: (2023)

Synthesis of thia-Michael-Type Adducts between Naphthoquinones and N-Acetyl-L-Cysteine and Their Biological Activity
por: Micheletti, Gabriele, et al.
Publicado: (2022)

A microscopic description of SARS-CoV-2 main protease inhibition with Michael acceptors. Strategies for improving inhibitor design
por: Ramos-Guzmán, Carlos A., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_r0queicsobkqg99i6cqhmu84pv